P Marbach
Overview
Explore the profile of P Marbach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
731
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kovarik J, Bartlett M, Rordorf C, Antunes M, Winter S, Marbach P, et al.
Int J Clin Pharmacol Ther
. 2010 Feb;
48(2):103-8.
PMID: 20137762
Introduction: Sotrastaurin is an immunosuppressant that blocks T-lymphocyte activation via protein kinase C inhibition. The authors determined whether a pharmacokinetic interaction occurs between sotrastaurin and everolimus, both of which are...
2.
Dimaraki E, Jaffe C, Bowers C, Marbach P, Barkan A
Am J Physiol Endocrinol Metab
. 2001 Feb;
280(3):E489-95.
PMID: 11171604
To test whether endogenous hypothalamic somatostatin (SRIH) fluctuations are playing a role in the generation of growth hormone (GH) pulses, continuous subcutaneous octreotide infusion (16 microg/h) was used to create...
3.
Kaal A, Orskov H, Nielsen S, Pedroncelli A, Lancranjan I, Marbach P, et al.
Eur J Endocrinol
. 2000 Oct;
143(3):353-61.
PMID: 11022177
Objective: Previous studies have indicated that antibody formation against octreotide is extremely rare. We examined the occurrence of octreotide antibody formation after treatment with three administration forms in large populations...
4.
Comets E, Mentre F, Kawai R, Nimmerfall F, Marbach P, Vonderscher J
J Pharm Sci
. 2000 Aug;
89(9):1123-33.
PMID: 10944377
Long-acting repeatable formulations (LAR) based on polymeric microspheres were manufactured to deliver octreotide, an octapeptide analogue used in acromegaly. We developed a model to describe the complex triphasic concentration versus...
5.
Thanou M, Verhoef J, Marbach P, Junginger H
J Pharm Sci
. 2000 Jun;
89(7):951-7.
PMID: 10861597
Octreotide acetate is a somatostatin analogue used for the control of endocrine tumors of the gastrointestinal (GI) tract and the treatment of acromegaly. The oral absorption of octreotide is limited...
6.
Comets E, Mentre F, Nimmerfall F, Kawai R, Mueller I, Marbach P, et al.
J Control Release
. 1999 May;
59(2):197-205.
PMID: 10332054
Octreotide (octreotide-acetate, Sandostatin(R)) is a somatostatin analogue, used in long-term treatment of acromegaly. The present study describes the absorption profile in rabbits of octreotide after release from the long-acting formulation...
7.
Rosch F, Herzog H, Stolz B, Brockmann J, Kohle M, Muhlensiepen H, et al.
Eur J Nucl Med
. 1999 Apr;
26(4):358-66.
PMID: 10199941
[90Y]DOTA-DPhe1-Tyr3-octreotide ([90Y]-SMT487) has been suggested as a promising radiotherapeutic agent for somatostatin receptor-expressing tumours. In order to quantify the in vivo parameters of this compound and the radiation doses delivered...
8.
Marbach P, BAUER W, Bodmer D, Briner U, Bruns C, KAY A, et al.
Pharm Biotechnol
. 1998 Oct;
11:183-209.
PMID: 9760681
No abstract available.
9.
Damge C, Vonderscher J, Marbach P, Pinget M
J Pharm Pharmacol
. 1997 Nov;
49(10):949-54.
PMID: 9364401
Poly(alkyl cyanoacrylate) nanocapsules have been used as biodegradable polymeric drug carriers for subcutaneous and peroral delivery of octreotide, a long-acting somatostatin analogue; their ability to reduce insulin secretion or prolactin...
10.
Flogstad A, Halse J, Bakke S, Lancranjan I, Marbach P, Bruns C, et al.
J Clin Endocrinol Metab
. 1997 Jan;
82(1):23-8.
PMID: 8989226
We have evaluated the long term effects and safety of Sandostatin LAR, a long acting formulation of octreotide, during 18 subsequent injections given every fourth week to 14 octreotide-sensitive acromegalic...